Cargando…
Microvascular dysfunction in COVID-19: the MYSTIC study
RATIONALE: Pre-clinical and autopsy studies have fueled the hypothesis that a dysregulated vascular endothelium might play a central role in the pathogenesis of ARDS and multi-organ failure in COVID-19. OBJECTIVES: To comprehensively characterize and quantify microvascular alterations in patients wi...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556767/ https://www.ncbi.nlm.nih.gov/pubmed/33058027 http://dx.doi.org/10.1007/s10456-020-09753-7 |
_version_ | 1783594281370386432 |
---|---|
author | Rovas, Alexandros Osiaevi, Irina Buscher, Konrad Sackarnd, Jan Tepasse, Phil-Robin Fobker, Manfred Kühn, Joachim Braune, Stephan Göbel, Ulrich Thölking, Gerold Gröschel, Andreas Pavenstädt, Hermann Vink, Hans Kümpers, Philipp |
author_facet | Rovas, Alexandros Osiaevi, Irina Buscher, Konrad Sackarnd, Jan Tepasse, Phil-Robin Fobker, Manfred Kühn, Joachim Braune, Stephan Göbel, Ulrich Thölking, Gerold Gröschel, Andreas Pavenstädt, Hermann Vink, Hans Kümpers, Philipp |
author_sort | Rovas, Alexandros |
collection | PubMed |
description | RATIONALE: Pre-clinical and autopsy studies have fueled the hypothesis that a dysregulated vascular endothelium might play a central role in the pathogenesis of ARDS and multi-organ failure in COVID-19. OBJECTIVES: To comprehensively characterize and quantify microvascular alterations in patients with COVID-19. METHODS: Hospitalized adult patients with moderate-to-severe or critical COVID-19 (n = 23) were enrolled non-consecutively in this prospective, observational, cross-sectional, multi-center study. Fifteen healthy volunteers served as controls. All participants underwent intravital microscopy by sidestream dark field imaging to quantify vascular density, red blood cell velocity (V(RBC)), and glycocalyx dimensions (perfused boundary region, PBR) in sublingual microvessels. Circulating levels of endothelial and glycocalyx-associated markers were measured by multiplex proximity extension assay and enzyme-linked immunosorbent assay. MEASUREMENTS AND MAIN RESULTS: COVID-19 patients showed an up to 90% reduction in vascular density, almost exclusively limited to small capillaries (diameter 4–6 µm), and also significant reductions of V(RBC). Especially, patients on mechanical ventilation showed severe glycocalyx damage as indicated by higher PBR values (i.e., thinner glycocalyx) and increased blood levels of shed glycocalyx constituents. Several markers of endothelial dysfunction were increased and correlated with disease severity in COVID-19. PBR (AUC 0.75, p = 0.01), ADAMTS13 (von Willebrand factor-cleaving protease; AUC 0.74, p = 0.02), and vascular endothelial growth factor A (VEGF-A; AUC 0.73, p = 0.04) showed the best discriminatory ability to predict 60-day in-hospital mortality. CONCLUSIONS: Our data clearly show severe alterations of the microcirculation and the endothelial glycocalyx in patients with COVID-19. Future therapeutic approaches should consider the importance of systemic vascular involvement in COVID-19. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10456-020-09753-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7556767 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-75567672020-10-15 Microvascular dysfunction in COVID-19: the MYSTIC study Rovas, Alexandros Osiaevi, Irina Buscher, Konrad Sackarnd, Jan Tepasse, Phil-Robin Fobker, Manfred Kühn, Joachim Braune, Stephan Göbel, Ulrich Thölking, Gerold Gröschel, Andreas Pavenstädt, Hermann Vink, Hans Kümpers, Philipp Angiogenesis Original Paper RATIONALE: Pre-clinical and autopsy studies have fueled the hypothesis that a dysregulated vascular endothelium might play a central role in the pathogenesis of ARDS and multi-organ failure in COVID-19. OBJECTIVES: To comprehensively characterize and quantify microvascular alterations in patients with COVID-19. METHODS: Hospitalized adult patients with moderate-to-severe or critical COVID-19 (n = 23) were enrolled non-consecutively in this prospective, observational, cross-sectional, multi-center study. Fifteen healthy volunteers served as controls. All participants underwent intravital microscopy by sidestream dark field imaging to quantify vascular density, red blood cell velocity (V(RBC)), and glycocalyx dimensions (perfused boundary region, PBR) in sublingual microvessels. Circulating levels of endothelial and glycocalyx-associated markers were measured by multiplex proximity extension assay and enzyme-linked immunosorbent assay. MEASUREMENTS AND MAIN RESULTS: COVID-19 patients showed an up to 90% reduction in vascular density, almost exclusively limited to small capillaries (diameter 4–6 µm), and also significant reductions of V(RBC). Especially, patients on mechanical ventilation showed severe glycocalyx damage as indicated by higher PBR values (i.e., thinner glycocalyx) and increased blood levels of shed glycocalyx constituents. Several markers of endothelial dysfunction were increased and correlated with disease severity in COVID-19. PBR (AUC 0.75, p = 0.01), ADAMTS13 (von Willebrand factor-cleaving protease; AUC 0.74, p = 0.02), and vascular endothelial growth factor A (VEGF-A; AUC 0.73, p = 0.04) showed the best discriminatory ability to predict 60-day in-hospital mortality. CONCLUSIONS: Our data clearly show severe alterations of the microcirculation and the endothelial glycocalyx in patients with COVID-19. Future therapeutic approaches should consider the importance of systemic vascular involvement in COVID-19. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10456-020-09753-7) contains supplementary material, which is available to authorized users. Springer Netherlands 2020-10-14 2021 /pmc/articles/PMC7556767/ /pubmed/33058027 http://dx.doi.org/10.1007/s10456-020-09753-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Paper Rovas, Alexandros Osiaevi, Irina Buscher, Konrad Sackarnd, Jan Tepasse, Phil-Robin Fobker, Manfred Kühn, Joachim Braune, Stephan Göbel, Ulrich Thölking, Gerold Gröschel, Andreas Pavenstädt, Hermann Vink, Hans Kümpers, Philipp Microvascular dysfunction in COVID-19: the MYSTIC study |
title | Microvascular dysfunction in COVID-19: the MYSTIC study |
title_full | Microvascular dysfunction in COVID-19: the MYSTIC study |
title_fullStr | Microvascular dysfunction in COVID-19: the MYSTIC study |
title_full_unstemmed | Microvascular dysfunction in COVID-19: the MYSTIC study |
title_short | Microvascular dysfunction in COVID-19: the MYSTIC study |
title_sort | microvascular dysfunction in covid-19: the mystic study |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556767/ https://www.ncbi.nlm.nih.gov/pubmed/33058027 http://dx.doi.org/10.1007/s10456-020-09753-7 |
work_keys_str_mv | AT rovasalexandros microvasculardysfunctionincovid19themysticstudy AT osiaeviirina microvasculardysfunctionincovid19themysticstudy AT buscherkonrad microvasculardysfunctionincovid19themysticstudy AT sackarndjan microvasculardysfunctionincovid19themysticstudy AT tepassephilrobin microvasculardysfunctionincovid19themysticstudy AT fobkermanfred microvasculardysfunctionincovid19themysticstudy AT kuhnjoachim microvasculardysfunctionincovid19themysticstudy AT braunestephan microvasculardysfunctionincovid19themysticstudy AT gobelulrich microvasculardysfunctionincovid19themysticstudy AT tholkinggerold microvasculardysfunctionincovid19themysticstudy AT groschelandreas microvasculardysfunctionincovid19themysticstudy AT pavenstadthermann microvasculardysfunctionincovid19themysticstudy AT vinkhans microvasculardysfunctionincovid19themysticstudy AT kumpersphilipp microvasculardysfunctionincovid19themysticstudy |